Dowd S E, Sun Y, Smith E, Kennedy J P, Jones C E, Wolcott R
US Department of Agriculture ARS Livestock Issues Research Unit, Lubbock, Texas, USA.
J Wound Care. 2009 Dec;18(12):508, 510-12. doi: 10.12968/jowc.2009.18.12.45608.
To evaluate the efficacy of several biofilm effectors in inhibiting biofilm formation in an in vitro multi-species chronic wound biofilm model.
The Lubbock Chronic Wound Biofilm (LCWB) model has been described in detail elsewhere. Pathogens used in the model are Pseudomonas aeruginosa, Enterococcus faecalis and Staphylococcus aureus. These are three of the most important species associated with biofilms. Here, the model was exposed to the following biofilm effectors: xylitol, salicylic acid, farnesol, erythritol and two proprietary, semi-solid, wound-dressing formulations currently under development (Sanguitec gels).
Biofilm formation was completely inhibited in the LCWB model following treatment with 20% xylitol, 10% erythritol, 1,000 microg/ml farnesol, 20mM salicylic acid or 0.1% of either of the two Sanguitec gel formulations. Salicylic acid specifically inhibited S. aureus (p<0.01) at 10mM and 20mM, consequently increasing the ratios of P. aeruginosa and E. faecalis within the biofilm. Xylitol had an increasing inhibitory effect on P. aeruginosa (p<0.01) at all concentrations evaluated. Erythritol had an inhibitory effect on P. aeruginosa and S. aureus growth (p<0.01) at over 5% concentrations. The inhibitory effect of both Sanguitec gel formulations was more broadly effective, with an increasingly inhibitory effect on all LCWB species (p<0.01).
The LCWB model provides a multi-species format with which to evaluate the effect of biofilm effectors on wound flora in a biofilm phenotype. These results suggest that different treatments can target specific populations within a biofilm. Salicylic acid preferentially targeted S. aureus, xylitol preferentially targeted P. aeruginosa, while erythritol preferentially targeted both P. aeruginosa and S. aureus. In contrast, the two Sanguitec gel formulations provided a broad, less preferential, inhibition of biofilm development.
Research and Testing Laboratory is a for-profit enterprise that develops molecular methods and performs service research work on biofilms. Sanguitec gel was developed by JPK and CEJ.
在体外多物种慢性伤口生物膜模型中评估几种生物膜效应物抑制生物膜形成的效果。
拉伯克慢性伤口生物膜(LCWB)模型已在其他地方详细描述。该模型中使用的病原体为铜绿假单胞菌、粪肠球菌和金黄色葡萄球菌。这些是与生物膜相关的最重要的三个物种。在此,该模型被暴露于以下生物膜效应物:木糖醇、水杨酸、法尼醇、赤藓糖醇以及两种目前正在研发的专利半固体伤口敷料制剂(Sanguitec凝胶)。
在用20%木糖醇、10%赤藓糖醇、1000微克/毫升法尼醇、20毫摩尔水杨酸或两种Sanguitec凝胶制剂中任一种的0.1%处理后,LCWB模型中的生物膜形成被完全抑制。水杨酸在10毫摩尔和20毫摩尔时特异性抑制金黄色葡萄球菌(p<0.01),从而增加了生物膜中铜绿假单胞菌和粪肠球菌的比例。木糖醇在所有评估浓度下对铜绿假单胞菌均有增强的抑制作用(p<0.01)。赤藓糖醇在浓度超过5%时对铜绿假单胞菌和金黄色葡萄球菌的生长有抑制作用(p<0.01)。两种Sanguitec凝胶制剂的抑制作用更广泛有效,对所有LCWB物种的抑制作用不断增强(p<0.01)。
LCWB模型提供了一种多物种形式,可用于评估生物膜效应物对生物膜表型伤口菌群的影响。这些结果表明不同的处理方法可以针对生物膜内的特定菌群。水杨酸优先靶向金黄色葡萄球菌,木糖醇优先靶向铜绿假单胞菌,而赤藓糖醇优先靶向铜绿假单胞菌和金黄色葡萄球菌。相比之下,两种Sanguitec凝胶制剂对生物膜形成提供了广泛的、较少选择性的抑制作用。
研究与测试实验室是一家营利性企业,开发分子方法并开展生物膜方面的服务研究工作。Sanguitec凝胶由JPK和CEJ研发。